Cargando…
The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset
Nowadays, it is well accepted that inflammation is a critical player in cancer, being, in most cases, the main character of the process. Different types of tumor arise from sites of infection or chronic inflammation. This non-resolving inflammation is responsible for tumor development at different l...
Autores principales: | Digifico, Elisabeth, Balinzo, Silvia, Belgiovine, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865698/ https://www.ncbi.nlm.nih.gov/pubmed/33513730 http://dx.doi.org/10.3390/ijms22031224 |
Ejemplares similares
-
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment
por: Allavena, Paola, et al.
Publicado: (2022) -
Macrophages and cancer stem cells: a malevolent alliance
por: Allavena, Paola, et al.
Publicado: (2021) -
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing
por: Belgiovine, Cristina, et al.
Publicado: (2020) -
Mechanotransduction in tumor progression: The dark side of the force
por: Broders-Bondon, Florence, et al.
Publicado: (2018) -
Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy
por: Belgiovine, Cristina, et al.
Publicado: (2021)